Raquel Bouça-Machado

Dr. Raquel Bouça-Machado

Instituto de Medicina Molecular, 1649-028 Lisbon, Portuga; CNS—Campus Neurológico, 2560-280 Torres Vedras, Portugal
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2019 in Movement Disorders Clinical Practice
Verified
Journal Article
Closed access
PDF file
RBRaquel Bouça-Machado
Raquel Bouça-Machado
ARAna Rosário
Ana Rosário
Daniel Gomes CaldeiraDaniel Gomes Caldeira
Daniel Gomes Caldeira
ACAna Castro Caldas
Ana Castro Caldas
DGDaniela Guerreiro
Daniela Guerreiro
Joaquim FerreiraJoaquim Ferreira
Joaquim Ferreira

25 January 2017 in BMC Palliative Care
Verified
Journal Article
Open access
PDF file
RBRaquel Bouça-Machado
Raquel Bouça-Machado
MRMadalena Rosário
Madalena Rosário
JAJoana Alarcão
Joana Alarcão
LCLeonor Correia-Guedes
Leonor Correia-Guedes
DADaisy Abreu
Daisy Abreu
Joaquim FerreiraJoaquim Ferreira
Joaquim Ferreira
Over the past decades there has been a significant increase in the number of published clinical trials in palliative care. However, empirical evidence suggests that there are methodological problems in the design and conduct of studies, which raises questions about the validity and generalisability of the results and of the strength of the available evidence. We sought to evaluate the methodological characteristics and assess the quality of reporting of clinical trials in palliative care. We performed a systematic review of published clinical trials assessing therapeutic interventions in palliative care. Trials were identified using MEDLINE (from its inception to February 2015). We assessed methodological characteristics and describe the quality of reporting using the Cochrane Risk of Bias tool. We retrieved 107 studies. The most common medical field studied was oncology, and 43.9% of trials evaluated pharmacological interventions. Symptom control and physical dimensions (e.g. intervention on pain, breathlessness, nausea) were the palliative care-specific issues most studied. We found under-reporting of key information in particular on random sequence generation, allocation concealment, and blinding. While the number of clinical trials in palliative care has increased over time, methodological quality remains suboptimal. This compromises the quality of studies. Therefore, a greater effort is needed to enable the appropriate performance of future studies and increase the robustness of evidence-based medicine in this important field.

17 February 2018 in Journal of Parkinson’s Disease
Verified
Journal Article
Open access
PDF file
RBRaquel Bouça-Machado
Raquel Bouça-Machado
WMWalter Maetzler
Walter Maetzler
Joaquim FerreiraJoaquim Ferreira
Joaquim Ferreira
Although yet poorly defined and often misused, the concept of functional mobility has been used in research studies as a more global and ecological outcome of patients’ health status. Functional mobility is a person’s physiological ability to move independently and safely in a variety of environments in order to accomplish functional activities or tasks and to participate in the activities of daily living, at home, work and in the community. Parkinson’s disease (PD) has a direct impact on patients’ motor control and on mobility in general. Even with optimal medical management, the progression of PD is associated with mounting impairments at different levels of body function, causing marked limitations in a wide variety of activities, as well as a severe disability and loss of autonomy. Despite this, for everyday functioning PD patients need to have a good functional mobility that allow them to get around effortlessly in a reasonable amount of time to access to the same environments as others. This paper reviewed the concept of functional mobility applied to PD. This was done through an International Classification of Functioning and Disability (ICF) perspective. Recommendations to address the known factors that contribute to a poor functional mobility were outlined while suggestions for clinical practice and research were made.

26 November 2019 in Movement Disorders Clinical Practice
Verified
Journal Article
Closed access
PDF file
RBRaquel Bouça-Machado
Raquel Bouça-Machado
GDGonçalo Duarte
Gonçalo Duarte
MPMaria Patriarca
Maria Patriarca
ACAna Castro Caldas
Ana Castro Caldas
JAJoana Alarcão
Joana Alarcão
Joaquim FerreiraJoaquim Ferreira
Joaquim Ferreira

6 February 2020 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
JGJohanna Geritz
Johanna Geritz
SMSara Maetzold
Sara Maetzold
MSMaren Steffen
Maren Steffen
APAndrea Pilotto
Andrea Pilotto
MCMarta Francisca Corrà
Marta Francisca Corrà
WMWalter Maetzler
Walter Maetzler
Background: Motor and cognitive deficits and consequently mobility problems are common in geriatric patients. The currently available methods for diagnosis and for the evaluation of treatment in this vulnerable cohort are limited. The aims of the ComOn (COgnitive and Motor interactions in the Older populatioN) study are (i) to define quantitative markers with clinical relevance for motor and cognitive deficits, (ii) to investigate the interaction between both motor and cognitive deficits and (iii) to assess health status as well as treatment outcome of 1000 geriatric inpatients in hospitals of Kiel (Germany), Brescia (Italy), Porto (Portugal), Curitiba (Brazil) and Bochum (Germany). Methods: This is a prospective, explorative observational multi-center study. In addition to the comprehensive geriatric assessment, quantitative measures of reduced mobility and motor and cognitive deficits are performed before and after a two week’s inpatient stay. Components of the assessment are mobile technology-based assessments of gait, balance and transfer performance, neuropsychological tests, frailty, sarcopenia, autonomic dysfunction and sensation, and questionnaires to assess behavioral deficits, activities of daily living, quality of life, fear of falling and dysphagia. Structural MRI and an unsupervised 24/7 home assessment of mobility are performed in a subgroup of participants. The study will also investigate the minimal clinically relevant change of the investigated parameters. Discussion: This study will help form a better understanding of symptoms and their complex interactions and treatment effects in a large geriatric cohort.